Bragar Eagel &amp; Squire, P.C., a shareholder rights law firm, reminds investors of DexCom, Inc. and Wildermuth Fund about upcoming deadlines to serve as lead plaintiff in class action lawsuits. The DexCom lawsuit alleges false and misleading statements about the G6 and G7 devices, while the Wildermuth Fund lawsuit claims miscalculation of investment fair value and intentional inflation of net asset value. Investors in both companies are encouraged to contact the firm regarding their rights.

德康醫療

<p>Bragar Eagel & Squire, P.C.，一家股東權益律師事務所，提醒 DexCom, Inc.和 Wildermuth Fund 的投資者注意即將到來的截止日期，以擔任集體訴訟的主要原告。DexCom 的訴訟指控其關於 G6 和 G7 設備的虛假和誤導性陳述，而 Wildermuth Fund 的訴訟則聲稱投資公允價值的錯誤計算和故意誇大淨資產值。鼓勵這兩家公司的投資者聯繫該事務所以瞭解他們的權利</p>

Bragar Eagel & Squire, P.C. 敦促德康醫療和 Wildermuth 的投資者在即將到來的截止日期之前聯繫該公司，以瞭解他們的權利